Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2002
06/06/2002WO2002044422A2 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits
06/06/2002WO2002044396A1 Photochemical internalization for delivery of molecules into the cytosol
06/06/2002WO2002044395A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol
06/06/2002WO2002044384A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
06/06/2002WO2002044380A2 Master bone formation transcription factor: compositions and methods of use
06/06/2002WO2002044379A2 Transforming growth factor-beta-related molecules and uses thereof
06/06/2002WO2002044377A2 Obp1:a protein selectively expressed in osteoblasts
06/06/2002WO2002044374A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
06/06/2002WO2002044371A1 Human protooncogene and protein encoded therein
06/06/2002WO2002044370A1 Human cervical cancer 2 protooncogene and protein encoded therein
06/06/2002WO2002044366A2 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
06/06/2002WO2002044364A2 Polypeptides involved in immune response
06/06/2002WO2002044361A2 Eukaryotic expression libraries based on double lox recombination and methods of use
06/06/2002WO2002044346A2 Stem cells, method for expansion in vitro and use thereof
06/06/2002WO2002044345A1 Methods and products for manipulating hematopoietic stem cells
06/06/2002WO2002044344A2 Basal cell carcinoma cultures, methods related thereto and their use
06/06/2002WO2002044343A2 Tolerizing allografts of pluripotent stem cells
06/06/2002WO2002044342A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof
06/06/2002WO2002044341A2 Method and apparatus for multi-layer growth of anchorage-dependent cells
06/06/2002WO2002044338A2 Growth of human dendritic cells for cancer immunotherapy in closed system using microcarrier beads
06/06/2002WO2002044336A2 Method of making a protein polymer and uses of the polymer
06/06/2002WO2002044321A2 Rna interference mediating small rna molecules
06/06/2002WO2002044320A2 Human elongase genes and uses thereof
06/06/2002WO2002044319A2 Spatially directed ejection of cells from a carrier fluid
06/06/2002WO2002044210A2 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
06/06/2002WO2002044209A2 Cytonkine receptor zcytor19
06/06/2002WO2002044207A1 Immunotherapeutic methods and molecules
06/06/2002WO2002044206A2 Membrane fusion proteins derived from reovirus
06/06/2002WO2002044202A2 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof
06/06/2002WO2002044199A2 Neurotoxins with enhanced target specificity
06/06/2002WO2002043661A2 Recombinant anti-cd30 antibodies and uses thereof
06/06/2002WO2002043660A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
06/06/2002WO2002043651A2 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
06/06/2002WO2002043485A1 Storage solution containing photosensitizer for inactivation of biological contaminants
06/06/2002WO2002043478A2 Transgenic transchromosomal rodents for making human antibodies
06/06/2002WO2002043477A1 Method of constructing mouse suitable for the take, differentiation and proliferation of heterogenous cells, mouse constructed by this method and use of the mouse
06/06/2002WO2002013606A3 Improved insecticidal bacteria, and methods for making and using them
06/06/2002WO2002005843A3 Human rrp sequences and methods of use
06/06/2002WO2002000906A3 Replication deficient adenoviral tnf vector
06/06/2002WO2001096557A3 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same
06/06/2002WO2001094549A3 Methods of differentiating and protecting cells by modulating the p38/mef2 pathway
06/06/2002WO2001094414A3 THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE
06/06/2002WO2001090360A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/06/2002WO2001090334A3 Drug metabolizing enzymes
06/06/2002WO2001088116A9 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
06/06/2002WO2001083716A3 Immortalized lines of endothelial brain cells and therapeutic application thereof
06/06/2002WO2001079442A3 Albumin fusion proteins
06/06/2002WO2001077300A3 Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
06/06/2002WO2001064907A3 Lipid metabolism enzymes
06/06/2002WO2001064884A3 G12l, a gene associated with the thermal response
06/06/2002WO2001048209B1 Genes identified as required for proliferation of e. coli
06/06/2002WO2001036645A3 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
06/06/2002WO2001031014A3 G protein-coupled receptors expressed in human brain
06/06/2002WO2001023604A9 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
06/06/2002WO2000062034A9 Multistage electromagnetic separator for purifying cells, chemicals and protein structures
06/06/2002US20020069433 Amplifying reproduction of preferential plants; obtain cells, transform, express vector, propagate plant, monitor enzymatic activity of plant
06/06/2002US20020069425 Methods and genetic compositions to limit outcrossing and undesired gene flow in crop plants
06/06/2002US20020069424 Protein-protein interactions in neurodegenerative disorders
06/06/2002US20020069422 Proteins for use in the treatment of trypanosome infection, cancer, inflammation and immunological defects
06/06/2002US20020068825 Polypeptide for use in the treatment of nervous system disorders
06/06/2002US20020068824 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects
06/06/2002US20020068716 Pituitary-tumor-transforming-gene (PTTG) polypeptide expressed by pituitary tumor cells, which binds anti-PTTG antibody.
06/06/2002US20020068713 Genetic engineering of vascular grafts to resist disease
06/06/2002US20020068697 Peptides blocking vascular endothelial growth factor (VEGF) -mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
06/06/2002US20020068696 Modulating proliferation and apoptotic state of cells using agents that modulate the expression and/or activity of TRADE family polypeptides.
06/06/2002US20020068694 Glycosylated VEGF-B and method for increasing the amount of soluble VEGF-B
06/06/2002US20020068363 Enhancing cell competence by recursive sequence recombination
06/06/2002US20020068359 Nucleotide sequences coding regulatory sequences; for use in generating genetically engineered plant
06/06/2002US20020068354 Genetically engineering hematopoietic progenitor cells; obtain cells, transform with vector, monitor cells for expression of vector proteins
06/06/2002US20020068353 Nucleotide sequence coding tumor polypeptide for use as anticarcinogeneic agents
06/06/2002US20020068346 Enzymatic polypeptide for use in the prevention and treatment of viral diseases
06/06/2002US20020068341 Human kallikrein
06/06/2002US20020068329 Fusion proteins for prodrug activation
06/06/2002US20020068323 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics
06/06/2002US20020068319 32 human secreted proteins
06/06/2002US20020068318 Production of human mutated proteins in human cells by means of homologous recombination
06/06/2002US20020068289 Screening library for preferential clones; obtain sample from library, insert into expression vector, transform cell, monitor cells for preferential gene expression, detect expression of preferential fuson protein
06/06/2002US20020068285 Compositions and methods for the therapy and diagnosis of breast cancer
06/06/2002US20020068270 Assessment of intracellular cysteine and glutathione concentrations
06/06/2002US20020068069 spsA polynucleotides and polypeptides
06/06/2002US20020068061 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions
06/06/2002US20020068053 Process for the production of anti-tumor Th1 cells
06/06/2002US20020068051 Generation and use of signal-plexes to develop specific cell types, tissues and /or organs
06/06/2002US20020068050 Made by transfecting with an expression vector of a nucleotide sequence encoding an active agent such as cytokines or peptide hormones; use in transplantation to prevent tissue rejection, wound healing
06/06/2002US20020068048 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
06/06/2002US20020068046 Use of stem cells derived from dermal skin
06/06/2002US20020068045 Such as neural progenitor cells capable of giving rise to mature somatic cells including neural cells and/or glial cells recognizable by expression of specific markers
06/06/2002US20020068044 Natural killer cell lines and methods of use
06/06/2002US20020066360 Supported lattice for cell cultivation
06/06/2002DE10058596A1 Verfahren zum Screening von chemischen Verbindungen zur Modulierung der Wechselwirkung einer EVH1-Domäne oder eines Proteins mit einer EVH1-Domäne mit einer EVH1-Bindedomäne oder einem Protein mit einer EVH1-Bindedomäne sowie ein Verfahren zum Nachweis besagter Wechselwirkung Method for screening chemical compounds for modulating the interaction of an EVH1 domain or a protein having an EVH1 domain with an EVH1-binding domain or a protein having an EVH1-binding domain and a method for the detection of said interaction
06/06/2002DE10058091A1 Isolierte Luziferasen Lu164, LuAL und Lu22, sowie deren Verwendung Isolated luciferases Lu164, LuAL and Lu22, and their use
06/06/2002CA2822983A1 System to separate frozen-thawed spermatozoa into x-chromosome bearing and y-chromosome bearing populations
06/06/2002CA2791831A1 Rna interference mediating small rna molecules
06/06/2002CA2436941A1 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
06/06/2002CA2436903A1 Immunotherapeutic methods and molecules
06/06/2002CA2431837A1 Method for diagnosing a tumor in a patient determining the concentration of pibf
06/06/2002CA2430745A1 Master bone formation transcription factor: compositions and methods of use
06/06/2002CA2430559A1 Method of making a protein polymer and uses of the polymer
06/06/2002CA2430526A1 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
06/06/2002CA2430485A1 Cytonkine receptor zcytor19